Cytokine profiling of ascites at primary surgery identifies an interaction of tumor necrosis factor-α and interleukin-6 in predicting reduced progression-free survival in epithelial ovarian cancer-Reference-Cited by-同舟云学术

Cytokine profiling of ascites at primary surgery identifies an interaction of tumor necrosis factor-α and interleukin-6 in predicting reduced progression-free survival in epithelial ovarian cancer

Published:2015-08 Issue:2 Volume:138 Page:352-357
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Kolomeyevskaya Nonna,Eng Kevin H.,Khan Anm Nazmul H.,Grzankowski Kassondra S.,Singel Kelly L.,Moysich Kirsten,Segal Brahm H.

Funder

RPCI-UPCI Ovarian Cancer SPORE

Roswell Park Alliance Foundation

2014-2015 Developmental Funds award from the Roswell Park Alliance Foundation

University at Buffalo School of Medicine Pilot Research Award

NCI Cancer Center Support

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Oncology

Reference40 articles.

1. Cancer Facts & Figs;American Cancer Society,2014

2. Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study;Winter;J. Clin. Oncol.,2007

3. Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group Study;Winter;J. Clin. Oncol.,2008

4. The prognostic value of pretreatment CA 125 in patients with advanced ovarian carcinoma: a Gynecologic Oncology Group study;Zorn;Cancer,2009

5. Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer;Zhang;N. Engl. J. Med.,2003

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patient‐derived acellular ascites fluid affects drug responses in ovarian cancer cell lines through the activation of key signalling pathways;Molecular Oncology;2024-09-08

2. Targeted Photodynamic Therapy using a Vectorized Photosensitizer coupled to Folic Acid Analog induces Ovarian Tumor Cell Death and inhibits IL-6-mediated Inflammation;Journal of Controlled Release;2024-07

3. The “Heater” of “Cold” Tumors–Blocking IL‐6;Advanced Biology;2024-05-22

4. Ovarian tumor cell-derived JAGGED2 promotes omental metastasis through stimulating the Notch signaling pathway in the mesothelial cells;Cell Death & Disease;2024-04-04

5. Clinical efficacy of plasmid encoding p62/SQSTM1 (Elenagen) in combination with gemcitabine in patients with platinum-resistant ovarian cancer: a randomized controlled trial;Frontiers in Oncology;2024-02-12